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The separation of sister chromatids at the metaphase-
to-anaphase transition is triggered by a protease called
separase that is activated by the destruction of an inhib-
itory chaperone (securin). This process is mediated by
a ubiquitin protein ligase called the anaphase-promot-
ing complex or cyclosome (APC/C), along with a pro-
tein called Cdc20. It is vital that separase not be acti-
vated before every single chromosome has been
aligned on the mitotic spindle. Kinetochores that have
not yet attached to microtubules catalyze the seque-
stration of Cdc20 by an inhibitor called Mad2. Recent
experiments shed important insight into how Mad2
molecules bound to centromeres through their asso-
ciation with a protein called Mad1 might be transfer-
red to Cdc20 and thereby inhibit securin’s de-
struction.
The logic of chromosome segregation during mitosis
has been well understood for nearly 80 years, and its
description therefore adorns the early chapters of most
biology textbooks. The aim is to segregate sister chro-
matids produced during the duplication of chromo-
somes to opposite poles of the cell prior to its division.
When successful, this process ensures that daughter
cells inherit the exact same set of chromosomes pos-
sessed by their parents. This is the foundation for the
capacity of unicellular organisms to proliferate indefi-
nitely, a property also shared by special stem cells in
multicellular organisms. The logic of mitosis is beguil-
ingly simple. It makes such sense that it is usually for-
gotten that the molecular mechanisms underlying it are
about as complicated as any in the vast repertoire of
mechanical systems found in living organisms. How in-
deed do cells ensure that sister DNAs move to opposite
poles of the cell with an accuracy that permits error in
less than one in 105 events?
The mechanical force responsible for chromosome
movement is provided by highly dynamic polar fila-
ments created by the oligomerization of tubulin. During
mitosis, the positive ends of microtubules are embed-
ded into specific structures on each chromatid known
as kinetochores while their negative ends are embed-
ded in large structures at opposite ends of the cells
called centrosomes. The traction of chromosomes to-
ward centrosomes arises either from depolymerization
of the minus ends of kinetochore-attached microtu-
bules while they remain embedded within centrosomes
or by depolymerization of kinetochore-attached micro-
tubules at their positive ends, a process that must oc-*Correspondence: knasmyth@imp.univie.ac.atcur without their detachment from kinetochores. Move-
ment along microtubules of motor proteins that are
simultaneously attached to kinetochores is also thought
to contribute to chromosome movement. If the kinet-
ochores of sister chromatids attach to microtubules
emanating from opposing poles (known as amphitelic
attachment or biorientation), then the forces exerted by
microtubules will pull sister DNAs in opposite directions
and thereby to opposite sides of the cell prior to its di-
vision.
A crucial feature of this mechanism is that cells must
somehow avoid the attachment of sister chromatids to
microtubules emanating from the same pole (known as
syntelic attachment), which would cause sisters to be
pulled to the same pole and would thereby cause the
production of aneuploid daughter cells. The solution to
this problem is to ensure that sister DNAs remain con-
nected with each other even after chromosomal DNA
has been fully replicated, a phenomenon known as sis-
ter chromatid cohesion (Miyazaki and Orr-Weaver,
1994). Because of sister chromatid cohesion, amphite-
lic but not syntelic attachment creates tension at kinet-
ochores and along the microtubules attached to them.
In the absence of such tension, a poorly understood
mechanism dependent on the Aurora B protein kinase
actively destabilizes kinetochore microtubules (Nicklas
and Ward, 1994; Tanaka et al., 2002). Syntelically at-
tached chromosomes, which do not give rise to ten-
sion, are thereby selectively eliminated.
If the first phases of mitosis, known as prophase,
prometaphase, and metaphase, are concerned with en-
suring that all chromosomes attain amphitelic attach-
ment, the second part of mitosis is about destroying
simultaneously the connections that link sister chroma-
tids, which permits their traction to opposite poles of
the cell during anaphase. Sister chromatid cohesion is
mediated by a multisubunit complex called cohesin,
which forms a gigantic ring structure whose integrity is
required for holding sister chromatids together (Haering
and Nasmyth, 2003). It has therefore been suggested
that cohesin might hold sister DNAs together by trap-
ping them inside its ring. When (and only when) all chro-
mosomes have attached amphitelically and thereby
come under tension, the cell activates a site-specific
protease called separase. This cleaves cohesin’s kleisin
subunit (Scc1), severs the cohesin ring, and destroys
the link between sister DNAs, which permits their trac-
tion finally toward opposite poles of the cell (Figure 1).
It is clearly vital that separase not become active be-
fore every single chromosome has come under tension.
Separase is kept inhibited during the first part of mito-
sis by two mechanisms: first by its association with an
inhibitory chaperone called securin and second due to
its phosphorylation by the Cdk1/cyclin B protein ki-
nase. The protease activity of separase is activated by
the simultaneous destruction of both securin and cyclin
B at the hands of the 26S proteosome, which is pre-
ceeded by their ubiquitinylation at the hands of a huge
multisubunit ubiquitin protein ligase called the ana-
phase-promoting complex or cyclosome (APC/C), whose
Cell
740a
(
t
t
p
b
s
d
a
t
i
a
a
c
t
c
d
s
m
f
o
t
s
t
s
L
f
a
t
t
m
b
t
t
b
s
1
c
p
t
r
i
b
T
y
p
t
b
1
Figure 1. Control of Sister Chromatid Segregation in Mitosis
Sister kinetochores attach to microtubules (green) that face oppo-
isite directions (amphitelic attachment) during prometaphase and
metaphase. The metaphase-to-anaphase transition is initiated by c
activation of separase. Until metaphase, separase is kept inactive a
by the binding of its inhibitory chaperone securin and by CDk1/ f
cyclin B-dependent phosphorylation. Activation of Cdc20 and the
danaphase-promoting complex/cyclosome (APC/C) causes destruc-
rtion of both securin and cyclin B, which leads to cleavage by separ-
tase of the Scc1 subunit of cohesin (black ring). Loss of sister chro-
umatid cohesion is accompanied by traction of sister chromatids to
opposite poles during anaphase. Unattached kinetochores in pro- e
metaphase promote the production of a form of Mad2 (Mad2-I) that C
sequesters Cdc20 and prevents it from promoting securin and (
cyclin B ubiquitinylation.
c
activity depends on an accessory protein called Cdc20
Zachariae and Nasmyth, 1999) (Figure 1). Cdc20 is
hought to recruit substrates to the APC/C by binding
o both partners. Cdc20’s C-terminal domain is com-
osed of WD40 repeats that form a β propeller that
inds both the APC/C and its substrates and a less
tructured but nevertheless highly important N-terminal
omain that is essential for controlling Cdc20’s activity.
Video microscopy has shown that the time taken for
ll chromosomes to biorient during the first part of mi-
osis can vary considerably between cells but that the
nterval between biorientation of the last chromosome
nd sister chromatid separation is relatively invariant
nd lasts about 20 min in mammalian tissue culture
ells (Rieder et al., 1994). Crucially, cells rarely if ever
rigger sister chromatid separation while there still exist
hromosomes that have not bioriented. Furthermore,
isassembly of microtubules by the addition of poisons
uch as colchicine and nocodazole delays sister chro-
atid separation as well as exit from the mitotic state
or many hours. The suggestion is that cells are capable
f monitoring the attachment of kinetochores to micro-
ubules and prevent activation of the APC/C and hence
eparase when kinetochores are unoccupied by micro-
ubules. This surveillance mechanism is known as the
pindle assembly checkpoint or SAC (Hoyt et al., 1991;
i and Murray, 1991). It has been suggested but never
ully proven that cells can also sense the lack of tension
t kinetochores and block APC/C activity also under
hese circumstances (Stern and Murray, 2001). Impor-
antly, work on yeast showed that cells carrying specific
utations in Cdc20’s N-terminal domain were incapa-
le of delaying destruction of securin and cyclin B in
he presence of spindle poisons, which suggested that
he SAC prevents separase activation and mitotic exit
y inhibiting the ability of Cdc20 to bind either its sub-
trates or the APC/C (Kim et al., 1998; Hwang et al.,
998). The SAC is a remarkable control mechanism be-
ause a single unattached kinetochore is capable of
reventing the activity of all Cdc20 molecules in a mi-
otic cell. Activation of the SAC can induce cells to ar-
est almost indefinitely in a metaphase-like state.
The SAC is essential in mammalian cells but surpris-
ngly not so in budding yeast, where chromosomes can
e segregated reasonably accurately without the SAC.
he relative unimportance of the SAC during mitosis in
east was fortunate, as it enabled the identification of
roteins necessary for the SAC by isolating mutants
hat failed to prevent exit from mitosis upon disassem-
ly of microtubules (Hoyt et al., 1991; Li and Murray,
991). Orthologs of four of these proteins are encoded
n most if not all eukaryotic genomes. In mammalian
ells, these proteins are known as Mad1, Mad2, BubR1,
nd Bub3. Though all four proteins are equally essential
or the SAC in vivo, Mad2 appears to have the most
irect role in inhibiting Cdc20’s activity. Mad2 binds di-
ectly to Cdc20 when the SAC is active, and, in vitro,
his binding is sufficient to block the APC/C’s ability to
biquitinylate securin or cyclin B (Li et al., 1997; Fang
t al., 1998). Mad2 is thought therefore to sequester
dc20 in an inactive state when the SAC is activated
Figure 1). Indeed, production of excess Mad2 is suffi-
ient to provoke cells to arrest in metaphase even when
ll chromosomes have bioriented successfully.
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mitosis nor are they greatly elevated when the SAC has
been activated. The suggestion is that the bulk of Mad2
protein is normally inactive and not capable of binding
stably to Cdc20 but that Mad2 is stimulated to do so
by kinetochores that are unoccupied by microtubules.
Mad2’s association with other checkpoint proteins ap-
pears to greatly augment its ability to inhibit the APC/C
(Sudakin et al., 2001). This phenomenon is as remark-
able as any described in eukaryotic cells. How does a
discrete and relatively small structure, namely a single
unoccupied kinetochore, catalyze the production of
Mad2 proteins capable of binding and inhibiting Cdc20?
Moreover, how does an unoccupied kinetochore pro-
duce enough “inhibitory” Mad2 to sequester most if not
all of the Cdc20 protein in the cell? This is all the more
remarkable when one considers that yeast kinet-
ochores bind only a single microtubule and that va-
cancy of just one such site is capable of preventing
almost permanently the metaphase-to-anaphase tran-
sition.
How then do unoccupied kinetochores trigger Mad2
to adopt a form capable of inhibiting Cdc20? The find-
ing that Mad2 oligomerizes to form what are now
thought to be dimers when produced in E. coli raised
the possibility that oligomeric Mad2 might be inhibitory,
while monomeric Mad2 might be incapable of inhibiting
Cdc20 (Fang et al., 1998). If true, unoccupied kinet-
ochores might have the ability to catalyze the formation
of inhibitory Mad2 oligomers. However, there has never
been any indication that Mad2 oligomerizes only in
cells with an active SAC. It has even been claimed, er-
roneously as it turns out, that oligomerization can be
eliminated by specific mutations without compromising
the SAC (Sironi et al., 2001). Mad2’s ability to dimerize
is indeed vital to the SAC, but the role of unoccupied
kinetochores is not simply to catalyze the formation of
oligomeric inhibitory Mad2.
Another crucial finding was the observation that a
fraction of Cdc20 and SAC proteins including Mad1and
Mad2 are concentrated at kinetochores of chromo-
somes that have not yet bioriented (Waters et al., 1998).
Might the Mad2 detected at such kinetochores be in
the process of being converted to an inhibitory form
capable of binding Cdc20? Might the sequestration of
Cdc20 by an inhibitory form of Mad2 occur exclusively
at such kinetochores? Importantly, is the flux of both
Mad2 and Cdc20 at unattached kinetochores sufficient
to inactivate all Cdc20 protein in the cell within a few
minutes? As far as I know, the actual fluxes of these
proteins at kinetochores have not yet been determined.
Any rigorous understanding of the SAC will require this
information. Nevertheless, photobleaching of fluores-
cent variants of Mad1 and Mad2 has revealed that most
Mad1 associated with unattached kinetochores does
not turn over rapidly, whereas a large fraction of Mad2
turns over rather rapidly (Howell et al., 2004). Other
studies also suggest that there exists a second popula-
tion of Mad2 at kinetochores that turns over more
slowly (Shah et al., 2004). Note that, despite the slow
turnover of Mad1 at the kinetochores of lagging chro-
mosomes, it nevertheless disappears abruptly from ki-
netochores once chromosomes biorient successfully.
The recruitment of Mad2 to kinetochores depends onMad1 but not vice versa (Chen et al., 1998). It seems
that one of the first events in activating the SAC is the
recruitment of Mad1 to kinetochores, which in turn re-
cruits Mad2. Mad1 is a long protein (718 amino acid
residues) composed largely of coiled coils. Like Mad2,
Mad1 oligomerizes to form Mad1:Mad1 dimers. Mad2
binds directly to Mad1, and it is presumably via this
interaction that Mad2 is recruited to kinetochores.
Thus, Mad2 forms complexes both with Mad1 and with
Cdc20. This has led to the notion that Mad1 not only
recruits Mad2 to kinetochores, but, once it has done
so, it induces a change in Mad2’s conformation that
permits Mad2 now to bind Cdc20 (Luo et al., 2004). This
concept is known as the “Mad2 exchange” model. The
Mad2 recruited to unattached kinetochores is pos-
tulated to exchange partners from Mad1 to Cdc20.
Clearly, the structure of Mad2’s complexes with
Mad1 and Cdc20 should provide insight into how Mad2
might be transferred from Mad1 to Cdc20. Such struc-
tures have indeed been determined and have shed fas-
cinating insight into how the SAC might function (see
below). Crystal and NMR structures show that Mad1
and Cdc20 bind to Mad2 in an apparently identical
fashion. Indeed, biochemical studies show that they
compete for the very same binding site. The simple no-
tion that the binding of Mad2 to Mad1 alters its confor-
mation so that the very same Mad2 molecule can now
bind Cdc20 is therefore implausible without invoking a
very complex series of events.
Before considering alternatives to the exchange
model and before considering the structural implica-
tions of Mad1’s mode of interaction with Mad2, let us
summarize the key facts that any model will have to
explain. (1) Mad1 binds unoccupied kinetochores and
is stably bound to them. (2) Mad2 is subsequently re-
cruited to kinetochores by binding Mad1 that has pre-
viously bound there. (3) There are potentially two pop-
ulations of Mad2 at kineotochores, one turning over
rapidly and one relatively stable. (4) Cdc20 is also re-
cruited to unoccupied kinetochores and forms com-
plexes with Mad2 whose mode of interaction may be
identical to that between Mad1 and Mad2. (5) Mad2
forms dimers. (6) Mutation of the amino acid residues
within Cdc20 that bind Mad2 abrogates the SAC. The
whole purpose of the SAC is presumably therefore to
catalyze the formation of complexes between Mad2
and Cdc20. (7) Bub3 and BubR1 also form complexes
with Cdc20. Their function is at the moment obscure,
but it might also be to facilitate complex formation be-
tween Mad2 and Cdc20. To these facts, we need to add
an additional assumption that is not supported by hard
facts but instead by intuition. Because the amount of
Mad1 at kinetochores is much less than the amount of
Cdc20 in the cell that must eventually be sequestered
by Mad2, the SAC cannot work merely by recruiting
Cdc20 to kinetochores where it binds to Mad2 recruited
there by Mad1.
What then is the structure of Mad2, and does this
shed insight into how Mad1 facilitates Mad2’s seque-
stration of Cdc20? The structure of Mad2 has been de-
termined by NMR (Luo et al., 2000) as well as by X-ray
crystallography (Sironi et al., 2002). By mutating Mad2’s
N terminus, Luo et al. (2000) managed to create a ver-
sion of Mad2 that formed mainly monomers and whose
Cell
742Figure 2. The Crystal Structure of Mad1:
Mad2 Complexesstructure could therefore be solved by NMR. This re- s
avealed a novel fold composed of α helices and β
sheets. Sequence analyses suggest that this fold, n
Cknown as the HORMA domain, is shared by a regulatory
subunit of DNA polymerase ζ called Rev7 and by the i
Mmeiosis-specific recombination protein Hop1 (Aravind
and Koonin, 1998). The fold consists of three layers: r
sa central layer formed by three α helices, a large six-
stranded β sheet on one side, and a short β hairpin on
nthe other side (Figure 3A). The structure was, however,
not particularly informative per se. More interesting was w
bthe finding that addition of a Cdc20 peptide sufficient
to bind Mad2 caused an extensive change in Mad2’s t
bstructure and that Mad2’s very C-terminal sequences
were essential for its interaction with Cdc20 (Luo et u
gal., 2000).
A key breakthrough in the field was the elucidation t
fby Sironi et al. of a crystal structure formed between
Mad2 and a fragment of Mad1 (Mad1485–584) that con- a
htained its Mad2 binding sequences and some but not
all of its coiled coils (Sironi et al., 2002). This segment m
lof Mad1 contained two α helices (α1 and α2) that sur-
rounded the short segment of Mad1 that actually binds a
bMad2. The key to growing these crystals was the elimi-
nation of Mad2’s ability to oligomerize, which otherwise 3
screates polydisperse complexes. Because oligomeriza-
tion was a property shared by Mad2 proteins from M
smany different organisms, Sironi et al. (2002) mutated
to alanine all conserved residues on Mad2 that were I
ppredicted to be exposed to solvent and hence available
for interaction with equivalent residues on another b
tMad2 molecule. It is important to point out that this
exercise was only possible because the existing NMR T
tstructure was available to guide their mutagenesistudies. They discovered that mutation of an arginine
t position 133 to alanine had the desired properties,
amely that Mad2R133A still bound to both Mad1 and
dc20 peptides but no longer formed complexes with
tself. Contrary to their initial claims (Sironi et al., 2001),
ad2R133A is not biologically functional, and the
easons for this are interesting and germane to our
tory (see below).
The Mad1485–584:Mad2R133A complex was a tetramer,
ot due to interaction between two Mad2 subunits,
hich had been eliminated by the Mad2R133A mutation,
ut because the Mad1485–584peptides were tightly held
ogether by a parallel intermolecular coiled coil formed
etween α1 helices from different Mad1 molecules (Fig-
re 2). The binding of Mad1 causes a remarkable reor-
anization of Mad2’s C-terminal domain compared with
he apo-Mad2 structure determined by NMR. While the
irst 160 residues of Mad2 are structurally invariant in
po and Mad1 bound Mad2, including all three of its α
elices (from left to right, α3, α1, and α2), the C-ter-
inal region containing β strands 7 and 8 as well as the
oop connecting β strand 7 with 6 is displaced from its
ssociation with helix α2 at the right side of Mad2 and
inds instead to helix α3 on its left side (Figures 2 and
). In apo-Mad2, β7 and β8 augment on its right-hand
ide a β sheet composed of β5, β4, and β6, while, in
ad1-Mad2 complexes, β7 and β8 augment this same
heet through association with β5 on its left-hand edge.
n the course of this huge rearrangement, β1 is dis-
laced as β5’s left-hand neighbor and the register of
oth β7 and β8 altered so that sequences at the ex-
reme C terminus of Mad2 are now included within β8.
he latter neatly explains the previous finding that dele-
ion of Mad2’s C-terminal amino acid sequences pre-
Review
743Figure 3. The Conformation of Mad2 before and after Binding Mad1 or Cdc20 Polypeptidesvents Mad2 from binding either Mad1 or Cdc20 (Luo et
al., 2000). This mutation (Mad2C) eliminates amino
acids that are included in the β8 of Mad1:Mad2 com-
plexes but does not substantially affect the β8 found in
apo-Mad2. Similar changes in Mad2’s structure were
also observed upon its association with an artificial
peptide known to compete for the binding of Mad1 or
Cdc20 (Luo et al., 2002).
What is remarkable about the rearrangement of Mad2
is that the Mad1 polypeptide chain is threaded through
the long loop that now connects Mad2’s β6 and its new
β7 (Figures 2 and 3). Because Mad1 contains extensive
peptide sequences on both sides of the section en-
closed by Mad2’s new loop, Mad1 becomes topologi-
cally trapped by Mad2 in a manner that resembles the
trapping of a car passenger by their safety seat belt.
Because Mad1 and Cdc20 contain similar Mad2 bind-
ing motifs (Luo et al., 2002; Sironi et al., 2002), Cdc20 is
presumably sequestered by Mad2 in a similar manner.
Thus, Mad2 blocks Cdc20 function by trapping Cdc20’s
N-terminal peptide sequences in the same manner as
it traps Mad1 at kinetochores. The key mystery is there-
fore how the locking of Mad1 within Mad2’s safety belt
at an unattached kinetochore facilitates the locking of
Cdc20 within Mad2 in a similar if not identical manner.
Both structural and biochemical data suggest that a
single molecule of Mad2 can only trap a single polypep-
tide, be it Mad1 or Cdc20. Thus, a single Mad2 safety
belt can accommodate only a single passenger at any
one time. Furthermore, due to the topological nature of
the association between Mad1 and Mad2, Mad1 pas-
sengers cannot readily be released from Mad2. They
cannot therefore easily be replaced by Cdc20 polypep-
tide sequences.
To envision how Mad1:Mad2 complexes might facili-
tate the formation of equivalent Cdc20:Mad2 com-
plexes, it is necessary to recall that Mad2 forms com-
plexes with itself as well as with Mad1 or Cdc20. Could
not Mad1 bind to one Mad2 subunit and thereby influ-
ence the probability that a second Mad2 subunit
adopts a conformation compatible with Cdc20 bind-ing? Note that a “Mad2 allosteric” model of this type
would only work if Mad1 was considerably less abun-
dant than Mad2 and therefore incapable of binding to
Mad2’s second subunit as well as its first. The simplest
version of the allosteric model would suppose that
Mad2 subunits adopt two different conformations, one
capable of binding Mad1 and Cdc20 (the R state) and
another that is not (the T state), and that Mad2 dimers
composed of subunits with different conformations
(Mad2R/Mad2T) are energetically unfavorable. Under
these circumstances, binding of a single Mad1 subunit
would favor the formation of Mad2R/Mad2R dimers,
one of whose binding sites would be occupied by Mad1
while the other would be free for Cdc20 to bind. The
fundamental problem with this model is that the Mad1:
Mad2R/Mad2R:Cdc20 complexes formed through this
conventional allosteric mechanism would remain stuck
at kinetochores. Mad2 would not turn over at kinet-
ochores and would never manage to sequester the entire
population of Cdc20 in the cell. Mad1 at kinetochores
must act catalytically and not stoichiometrically as pro-
posed by the allosteric model.
Though a simple allosteric model seems implausible,
the ability of Mad2 to oligomerize might still be crucial.
The actual structure of Mad2 dimers would presumably
be informative, but this has so far eluded both NMR
and X-ray crystallography. Nevertheless, a recent series
of biochemical experiments involving the analysis of
Mad1:Mad2 complexes by gel filtration has provided
key insights into the peculiar nature of Mad2 oligomers
(De Antoni et al., 2005). The results imply that Mad2
dimers only form between Mad2 subunits that are in
different conformations; that is, they form between a
Mad2 subunit whose safety belt has “closed” (with β7
and β8 adjacent to the left side of β5), with or without
a Mad1 or Cdc20 polypeptide topologically enclosed,
and a Mad2 subunit whose safety belt is in a state
ready to receive a passenger (with β7 and β8 adjacent
to the right side of β6). These two states are referred to
as C- and O-Mad2, respectively, though note that the
safety belt is not strictly open in the O state but rather
Cell
744ready to be opened and subsequently shut (Figure 3). C
pThus, the addition to Mad2 dimers of a Cdc20 peptide
causes the formation of Cdc20:Mad2 complexes r
pwhose Mad2 is exclusively in the C-Mad2 conformation
and cannot therefore oligomerize due to Mad2:Mad2 w
cinteractions. C-Mad2 cannot bind to a second Mad2
molecule in the same closed state. Likewise, Mad2C, m
cwhich is incapable of adopting the closed conformation
and is therefore locked in the O form, is incapable of M
Mforming oligomers and only forms Mad2 monomers.
The implication is that O-Mad2 can only bind a second A
tMad2 molecule if the latter is in a closed conformation.
According to this “template model” (Figure 4A), a C
pMad1 polypeptide bound to an unattached kinetochore
is trapped by a Mad2 protamer that will be in its C state C
Mand therefore capable of associating with a second
Mad2 protamer as long as the latter is in its O state. tFigure 4. The Mad2 Template Model
(A) C-Mad2 that has trapped Mad1 associ-
ated with an unattached kinetochore binds
O-Mad2, which in turn can trap Cdc20 and
thereby generate free Cdc20:C-Mad2 com-
plexes. The latter have the potential to cata-
lyze their own production via a mechanism
similar to their catalysis by Mad1:C-Mad2
complexes.
(B) p31comet is postulated to inactivate the
SAC by competing with O-Mad2 for binding
to C-Mad2.rucially, the O-Mad2 bound to Mad1:C-Mad2 com-
lexes in this manner would be in a state capable of
eceiving Cdc20. To detect formation of such com-
lexes in vitro, fluorescently labeled Mad2 (Alexa Mad2)
as added to preassembled unlabeled Mad1:C-Mad2
omplexes (De Antoni et al., 2005). After gel filtration,
uch of the Alexa Mad2 comigrated with Mad1:Mad2
omplexes. The explanation is that the preassembled
ad1:Mad2 complexes contained C-Mad2 bound to
ad1 and O-Mad2 bound to the C-Mad2 and that the
lexa Mad2 displaced the unlabeled O-Mad2 but not
he C-Mad2 bound to Mad1. Crucially, addition of a
dc20 peptide to preassembled Mad1:Mad2 com-
lexes completely failed to disrupt them; that is, the
dc20 peptide could not displace Mad1 trapped by
ad2. However, the same peptide nevertheless caused
he dissociation of most Alexa Mad2 from Mad1:
Review
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Alexa C-Mad2 complexes. When the same experiment
was repeated with Alexa Mad2C that is locked in the
O conformation, then this O-Mad2 protein was also in-
corporated into Mad1:Mad2 complexes, but, unlike
wild-type Mad2, the Alexa Mad2C protein could not be
displaced from the Mad1:C-Mad2 complexes by
Cdc20 peptides.
The implication is that Mad1:Mad2 complexes con-
tain two types of Mad2 protamer: one that has trapped
Mad1 and is in the C form and a second that is bound
to the first but is in an O conformation capable of trap-
ping a Cdc20 peptide. Importantly, once this second
Mad2 traps Cdc20 and now adopts a C conformation,
it drops off the Mad1:Mad2 complex. Mad2 bound to
Mad1 is therefore capable of providing a landing pad
for Mad2 protamers in their O conformation, which are
in turn primed to bind Cdc20, but, once they do so, the
Cdc20:C-Mad2 complex dissociates from the preexist-
ing Mad1:Mad2 landing pad (Figure 4A). The C-Mad2
bound to Mad1 provides as it were a “template” that
catalyzes the formation of what are essentially equiva-
lent Cdc20:C-Mad2 complexes.
This template model appears consistent with most if
not all the facts, but it is far from proven. What is most
important is that the model provides an explanation for
how Mad1 bound to kinetochores seeds the formation
of Cdc20:Mad2 complexes in a manner that is catalytic
and not merely stoichiometric. The model also explains
why there are both slow- and fast-turning-over popula-
tions of Mad2 at unattached kinetochores. The former
would be C-Mad2 that is interlocked with Mad1, while
the latter would be the O-Mad2 that binds to the C-Mad2
and is subsequently released from the Mad1 bound to
kinetochores due to Mad2’s association with Cdc20.
Note also that O-Mad2 may bind to C-Mad2 much less
tightly than Mad1 trapped by a C-Mad2. The real
beauty of the template model is that it no longer in-
vokes mysterious unknown forces. The next step must
be to solve the structure of Mad2 oligomers and
thereby describe the mechanism by which O-Mad2
binds to C-Mad2. This will be necessary to explain why
neither C-Mad2 nor O-Mad2 can bind to themselves.
Even without a structure of Mad2 dimers, it has nev-
ertheless been possible to identify residues within
Mad2 that are essential for its oligomerization but not
for its ability to sequester either Mad1 or Cdc20 poly-
peptides. As already pointed out, mutation of an argi-
nine at position 133 to alanine (Mad2R133A) enabled the
formation of Mad1:C-Mad2 crystals by compromising
Mad2’s ability to oligomerize. However, for clean bio-
chemical experiments, it was necessary to create a
Mad2 mutant that was also incapable of forming com-
plexes with otherwise wild-type Mad2 molecules. This
was achieved by mutating simultaneously arginine 133
to glutamic acid and an adjacent glutamine 134 to ala-
nine (Mad2R133E Q134A). Gel filtration experiments con-
firmed that Alexa-labeled Mad2R133E Q134A was both
monomeric and incapable of being incorporated into
preassembled Mad1:Mad2 complexes (De Antoni et al.,
2005). Crucially, the template model predicts that this
version of Mad2 should be defective in Mad2 function
in vivo. To test this, the endogenous Mad2 of HeLa cells
was knocked down by RNA interference (RNAi), and theability of RNAi-resistant Mad2 variants to restore SAC
function was tested. Such experiments suggested that
Mad2R133E Q134A was indeed nonfunctional. I for one
was not fully convinced by these experiments. The
techniques for manipulating tissue culture cells using
RNAi do not seem to be rigorous enough to establish
these sorts of facts unambiguously. However, I am told
that the equivalent mutation to Mad2R133A has since
been made in yeast (Mad2R126A) and has indeed been
found to be nonfunctional.
Another crucial prediction of the template model is
that Mad2 incapable of trapping Mad1 or Cdc20,
namely Mad2C, should nevertheless be capable of be-
ing recruited to mitotic kinetochores that have already
assembled Mad1:Mad2 complexes, while Mad2 inca-
pable of forming oligomers, namely Mad2R133E Q134A,
should not be capable of being recruited to such kinet-
ochores. This was tested by injecting Alexa-labeled
variants of Mad2 into mitotic HeLa cells (De Antoni et
al., 2005). As predicted, wild-type Mad2C associated
with kinetochores of prometaphase cells as well as
wild-type Mad2, but neither Mad2R133E Q134A nor
Mad2C R133E Q134A associated with such kinetochores.
A fascinating aspect of the template hypothesis is
that there is no reason that the principle by which
Mad1:C-Mad2 complexes catalyze the formation of
Cdc20:C-Mad2 complexes should not also apply to the
generation of Cdc20:C-Mad2 complexes by preexisting
Cdc20:C-Mad2 complexes. It is conceivable that the
Cdc20:C-Mad2 complexes that drop off the Mad1:
C-Mad2 complexes at unattached kinetochores start
an autocatalytic reaction in which Cdc20:C-Mad2 com-
plexes “breed” further Cdc20:C-Mad2 complexes.
Such a phenomenon could explain one of the great
mysteries of the SAC, namely the ability of a single un-
occupied kinetochore to cause the sequestration of the
entire pool of Cdc20 in inactive complexes with Mad2.
Another attractive feature of the template model is
that it provides an explanation for how a protein called
p31comet facilitates the escape of cells from cell cycle
arrest caused by the SAC. p31comet appears to share
several properties with O-Mad2, namely an ability to
bind C-Mad2 but not O-Mad2. This raises the possi-
bility that p31comet inactivates the SAC by acting as a
competitive inhibitor of O-Mad2. If so, p31comet would
bind to Mad1:Mad2 complexes assembled at kinet-
ochores and prevent them from recruiting O-Mad2,
thereby preventing their catalysis of Cdc20:C-Mad2
complex formation (Figure 4B). The structure of com-
plexes between p31comet and Mad2-C will clearly be il-
luminating.
It should be stressed that many features of the SAC
remain deeply mysterious, not least the function of pro-
teins like BubR1 and Bub3, which also form complexes
with Cdc20. Future experiments will be required to test
whether the binding of these proteins to Cdc20 some-
how facilitates the ability of O-Mad2 to trap Cdc20.
Also completely unexplained at the moment is how
Mad1:Mad2 complexes are only recruited to kinet-
ochores that are unoccupied by microtubules and have
not come under tension. It is also quite unclear how the
cell prevents O-Mad2 in the cytoplasm from sequester-
ing Cdc20 without the intervention of Mad1 bound to
unattached kinetochores or how the recruitment of
Cell
746HCdc20 to kinetochores contributes to its sequestration
rby O-Mad2 bound to Mad1:C-Mad2 complexes. A hall-
fmark of all important scientific breakthroughs is that
Hthey generate more ignorance than they do under-
H
standing, a principle that certainly seems to apply to C
the template model. The key point is that there exists K
for the first time a clear and testable hypothesis for one T
important cog in the SAC, namely the mechanism by s
which Mad1 might catalyze the formation of Cdc20: L
dMad2 complexes. This represents an important ad-
vance and provides a rigorous intellectual platform L
(within which other aspects of the SAC can begin to be
cincorporated. It will be interesting to find out whether
1other proteins containing Mad2’s HORMA domain will
Lprove to share Mad2’s remarkable properties.
W
In an age when a great deal of cant has been written p
about the coming of age of systems biology, the experi- 2
ments from Musacchio’s lab reveal the variety of ex- L
periments that are essential to understand complex c
cbiological control mechanisms in this day and age (De
Antoni et al., 2005). Structural biology, genetics, hard- L
acore biochemistry, and sophisticated imaging of tagged
dproteins in vivo are all required simply to begin to think
Mclearly about sophisticated biological processes, and
shighly sophisticated experiments are required before
None can begin to contemplate the utility of mathemati-
ical modeling. Future departments of systems biology
1
might take note. The Mad2 work also demonstrates the
R
futility of structural genomics, namely the solution of o
crystal structures without a parallel commitment to un- m
derstanding their biology. No insight into the mecha- 1
nism of the SAC could ever have emerged from struc- S
Ctures of SAC proteins without in parallel a huge
pinvestment by the structural lab itself into sophisticated
Bbiochemistry and cell biology.
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